Upgrade to SI Premium - Free Trial

Aditxt, Inc (ADTX)

0.01 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/17/25 *Est.)

Latest Headlines

Form 4 Aditxt, Inc. For: Jun 08 Filed by: HRT FINANCIAL LP June 16, 2026 9:14 AM - SEC Filing Form 4 Aditxt, Inc. For: Jun 11 Filed by: BANK OF AMERICA CORP /DE/ June 15, 2026 8:07 PM - SEC Filing Form 3 Aditxt, Inc. For: Jun 10 Filed by: BANK OF AMERICA NA June 15, 2026 1:03 PM - SEC Filing Form SCHEDULE 13G Aditxt, Inc. Filed by: Ni Andy June 15, 2026 10:29 AM - SEC Filing Form 4 Aditxt, Inc. For: Jun 08 Filed by: HRT FINANCIAL LP June 12, 2026 3:33 PM - SEC Filing Form SCHEDULE 13G/A Aditxt, Inc. Filed by: Xu Devon Xin June 11, 2026 9:25 PM - SEC Filing Form SCHEDULE 13G Aditxt, Inc. Filed by: Xu Devon Xin June 11, 2026 9:12 PM - SEC Filing Form SCHEDULE 13G Aditxt, Inc. Filed by: Diaz Rodriguez Agustin June 11, 2026 4:51 PM - SEC Filing Form 4 Aditxt, Inc. For: Jun 08 Filed by: HRT FINANCIAL LP June 11, 2026 3:09 PM - SEC Filing Form 4 Aditxt, Inc. For: Jun 09 Filed by: Gong Sandie June 10, 2026 9:51 PM - SEC Filing Form 3 Aditxt, Inc. For: Jun 09 Filed by: Gong Sandie June 10, 2026 9:35 PM - SEC Filing Form 8-K Aditxt, Inc. For: Jun 10 June 10, 2026 5:30 PM - SEC Filing Form 3 Aditxt, Inc. For: Jun 08 Filed by: HRT FINANCIAL LP June 10, 2026 3:45 PM - SEC Filing Form 8-K Aditxt, Inc. For: Jun 03 June 9, 2026 4:31 PM - SEC Filing Aditxt spins off Ignite Proteomics in $150 million deal June 9, 2026 7:45 AM - StreetInsider Aditxt Signed Definitive Agreement Valuing Ignite Proteomics at Approximately $150 Million June 9, 2026 7:45 AM - BizWire Form 4 Aditxt, Inc. For: Jun 04 Filed by: HRT FINANCIAL LP June 8, 2026 6:19 PM - SEC Filing Form 3 Aditxt, Inc. For: Jun 04 Filed by: HRT FINANCIAL LP June 8, 2026 6:06 PM - SEC Filing Ignite Proteomics Announces Prospective 10,000-Patient Oncology Registry to Evaluate Functional Proteomics in Cancer Therapy Selection June 8, 2026 8:15 AM - BizWire Form 8-K Aditxt, Inc. For: Jun 02 June 5, 2026 4:31 PM - SEC Filing Form 8-K Aditxt, Inc. For: May 29 June 1, 2026 8:30 AM - SEC Filing Aditxt names Jeffrey Busch as interim CEO June 1, 2026 8:15 AM - StreetInsider Aditxt, Inc. Appoints Jeffrey M. Busch as Interim Chief Executive Officer; Founder and Former CEO of $1B NYSE Enterprise Which Delivered ~8.5% Dividends to Shareholders June 1, 2026 8:15 AM - BizWire Form 8-K Aditxt, Inc. For: May 27 May 29, 2026 4:21 PM - SEC Filing Form PRE 14A Aditxt, Inc. For: May 22 May 22, 2026 5:04 PM - SEC Filing Form 10-Q Aditxt, Inc. For: Mar 31 May 20, 2026 4:31 PM - SEC Filing Form NT 10-Q Aditxt, Inc. For: Mar 31 May 15, 2026 4:28 PM - SEC Filing Form 8-K Aditxt, Inc. For: May 14 May 15, 2026 4:27 PM - SEC Filing Aditxt implements 1-for-27 reverse stock split starting May 18 May 14, 2026 8:15 AM - StreetInsider Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-27 Reverse Stock Split Effective at the Open of Trading on May 18, 2026 May 14, 2026 8:15 AM - BizWire Form 8-K Aditxt, Inc. For: May 06 May 8, 2026 4:20 PM - SEC Filing Form 8-K Aditxt, Inc. For: May 01 May 1, 2026 4:36 PM - SEC Filing Form 4 Aditxt, Inc. For: Apr 21 Filed by: HRT FINANCIAL LP April 27, 2026 3:13 PM - SEC Filing Form 424B3 Aditxt, Inc. April 23, 2026 7:12 PM - SEC Filing Form 4 Aditxt, Inc. For: Apr 21 Filed by: HRT FINANCIAL LP April 23, 2026 3:43 PM - SEC Filing Form 3 Aditxt, Inc. For: Apr 21 Filed by: HRT FINANCIAL LP April 23, 2026 3:37 PM - SEC Filing Form EFFECT Aditxt, Inc. April 22, 2026 6:07 AM - SEC Filing Dana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics’ RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patients April 20, 2026 8:15 AM - BizWire Form 8-K Aditxt, Inc. For: Apr 10 April 14, 2026 8:02 AM - SEC Filing Aditxt, Inc (ADTX) files for 148.28M share offering by selling stockholders April 13, 2026 6:12 AM - StreetInsider Form S-3 Aditxt, Inc. April 13, 2026 6:04 AM - SEC Filing Form 8-K/A Aditxt, Inc. For: Mar 10 April 7, 2026 4:03 PM - SEC Filing Form DEF 14A Aditxt, Inc. For: May 01 April 3, 2026 4:37 PM - SEC Filing Form 8-K Aditxt, Inc. For: Apr 01 April 2, 2026 9:14 AM - SEC Filing Form 10-K Aditxt, Inc. For: Dec 31 March 31, 2026 4:35 PM - SEC Filing Form 8-K Aditxt, Inc. For: Mar 27 March 30, 2026 8:01 AM - SEC Filing Form 424B5 Aditxt, Inc. March 27, 2026 5:02 PM - SEC Filing Form PRE 14A Aditxt, Inc. For: Mar 24 March 24, 2026 5:22 PM - SEC Filing Aditxt names Jeff Busch CEO of Ignite Proteomics subsidiary March 19, 2026 8:15 AM - StreetInsider Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer March 19, 2026 8:15 AM - BizWire Full Article List